Cross Marketing Group Inc. Logo

Cross Marketing Group Inc.

Delivers marketing insights via research and digital solutions using a large Japanese consumer panel.

3675 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
新宿区西新宿三丁目20番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Established in 2003, Cross Marketing Group Inc. is a comprehensive marketing solutions provider specializing in market research, digital marketing, and data marketing. The company offers a one-stop service for both qualitative and quantitative research, with a core focus on online methodologies. Leveraging one of Japan's largest consumer research panels, it delivers actionable insights to support client decision-making for product development and strategy. The Group's services also encompass a wide range of digital marketing and data-driven solutions, assisting clients in their digital transformation (DX) and marketing process optimization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 08:33
Regulatory News Service
確認書
Japanese 8.9 KB
2025-09-24 08:32
Annual Report
有価証券報告書-第13期(2024/07/01-2025/06/30)
Japanese 1.5 MB
2025-06-24 09:01
Share Issue/Capital Change
臨時報告書
Japanese 33.6 KB
2025-03-04 02:04
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.6 KB
2025-02-14 08:03
Regulatory News Service
確認書
Japanese 9.0 KB
2025-02-14 08:02
Interim Report
半期報告書-第13期(2024/07/01-2025/06/30)
Japanese 242.4 KB
2025-02-04 03:04
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.6 KB
2025-01-07 03:04
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.2 KB
2024-12-03 03:13
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.3 KB
2024-11-05 02:03
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.5 KB
2024-10-03 08:00
Post-Annual General Meeting Information
臨時報告書
Japanese 27.1 KB
2024-10-02 05:08
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.9 KB
2024-09-27 08:06
Governance Information
内部統制報告書-第12期(2023/07/01-2024/06/30)
Japanese 23.5 KB
2024-09-27 08:06
Registration Form
確認書
Japanese 8.9 KB
2024-09-27 08:05
Annual Report
有価証券報告書-第12期(2023/07/01-2024/06/30)
Japanese 1.5 MB

Automate Your Workflow. Get a real-time feed of all Cross Marketing Group Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cross Marketing Group Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
N/A

Talk to a Data Expert

Have a question? We'll get back to you promptly.